Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Study Phase:
2
Recruitment Status:
Trial Completed
Study Drug(s):
Glutamine
Number of Participants Being Recruited:
44
Single / Multi-Center:
Single Center
STUDY BACKGROUND INFORMATION:
This study willevaluate the safety and tolerability of aerolized glutathione compared with normal saline. The main outcome measure is pulmonary function testing (PFT)
ELIGIBILITY
Age:
>= 14 Years
FEV1:
>= 40 Percent Predicted
P. aeruginosa status:
Positive
B. cepacia status:
Not applicable
Other Primary Eligibility Requirements:
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.
